| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $13.77B | +176.9% |
| R&D Expense | $344.0M | -45.8% |
| SG&A Expense | $433.0M | +38.8% |
| Operating Income | $5.16B | +192.5% |
| Pre-tax Income | $3.36B | +54.1% |
| Income Tax | $630.0M | +44.2% |
| Net Income | $2.73B | +56.5% |
| EPS (Basic) | $0.93 | +47.6% |
| EPS (Diluted) | $0.86 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.35B | -34.7% |
| Accounts Receivable | $918.0M | +152.2% |
| Inventory | $253.0M | +48.0% |
| Current Assets | $4.04B | -11.4% |
| Total Assets | $53.45B | +22.9% |
| Current Liabilities | $4.34B | +22.6% |
| Long-term Debt | $34.20B | +16.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $6.57B | +205.5% |
| Capital Expenditures | $13.37B | -2.6% |
| Investing Cash Flow | -$13.22B | +6.6% |
| Financing Cash Flow | $5.46B | -49.2% |
| Free Cash Flow | -$6.80B | +41.2% |
| +50.9% |
| Total Liabilities |
| $41.45B |
| +16.4% |
| Stockholders' Equity | $6.74B | +132.8% |